WhiteLab GenomicsDelivering therapeutic genetic material safely to the correct target in the body is one of the big challenges of modern medicine. We talked to David Del Bourgo, CEO of WhiteLab Genomics, about how AI is helping design a new generation of vectors to tackle neurological diseases.
Tag Archive for: AI
Warsaw-based AI biology company Ingenix has raised €13m in a seed-extension financing round led by Sofinnova Partners, with participation from Inovo VC and OTB VC.
London-based IMU Biosciences has expanded its Series A financing to more than US$53m (£40m/€46m) in an oversubscribed round, as the company looks to scale its immune-profiling platform and move further into clinical applications.
Perceptic has raised a $12 million (€10.3 million) seed round to advance an AI operating system used by companies including CSL.
Cambridge-based Tolemy Bio has raised €1.4m in pre-seed financing to develop Orbit, an AI-native platform designed to help biopharma teams interpret, optimise and control cell-based therapeutic processes.
Unsplash+Novo Nordisk becomes the latest major pharma player to trust the future of its drug discovery to AI. However, the Danish pharma heavyweight is going one step further: The partnership with Open AI is set to embed advanced artificial intelligence across everything from early R&D to commercial operations.
The AI Circular Economy Conference 2026, organised by nova-Institute, brought together 116 participants from 15 countries in Cologne and online to explore the transformation of the chemical and materials industry supported and accelerated by artificial intelligence.
London-based Ternary Therapeutics has raised a €4.1 million seed round to expand its platform for designing molecular glue drugs, with Paris-based VC daphni leading the financing alongside Pace Ventures, i&i Biotech Fund and Future Planet Capital.
French AI biotech Owkin has spun out its diagnostics division as a new company, Waiv, raising $33 million in financing led by OTB Ventures and Alpha Intelligence Capital to scale AI-powered precision testing.
BeiersdorfAs a co-investor in the USD 25 million Series B round, Beiersdorf AG is signalling that artificial intelligence is becoming strategically important for skin research. The Hamburg-based group is participating through its venture unit in the AI biotech Turbine, founded in Budapest and now also headquartered in London.
Tag Archive for: AI
bioRN Life Science ClusterDive into one of Europe’s most vibrant life science ecosystems
On 3 February 2027, life – the biomedical convention returns to the Heidelberg Congress Center, bringing together around 500 scientists, entrepreneurs, investors and industry leaders from across Germany and neighbouring countries.
Hosted by bioRN Life Science Cluster, the conference offers a unique gateway into one of Europe’s strongest life science ecosystems. The Rhine-Neckar region combines world-class research institutions, global pharmaceutical companies, innovative SMEs and a rapidly growing startup community—creating an environment where scientific excellence meets entrepreneurship and where biomedical innovation is translated into real-world impact.
The scientific programme is built around two complementary tracks. Biomedical Innovations highlights breakthrough research, novel technologies and translational success stories emerging from the region’s vibrant ecosystem. AI in Health explores how artificial intelligence is reshaping every stage of biomedical innovation—from AI-driven drug discovery and computational biology to digital pathology, precision medicine and data-driven diagnostics. Beyond technological advances, the programme will also address key questions surrounding regulation, data integration and the evolving role of researchers, clinicians and industry as AI becomes an integral part of healthcare.
More than 30 exhibitors will showcase the latest technologies, services and innovations, while the exhibition area serves as a lively meeting point throughout the day. Short Lunch Talks provide practical learning nuggets during the breaks, offering fresh perspectives on emerging technologies, entrepreneurship and innovation in concise, inspiring sessions.
A particular highlight is the Young Scientists Pitch Competition, where outstanding early-career researchers present their most promising ideas to an expert jury and an audience of leading decision-makers from academia and industry—creating visibility for the next generation of biomedical innovators.
What truly distinguishes life is its exceptional networking atmosphere. With representatives from approximately 200 companies, research institutes and organisations, the convention offers countless opportunities to exchange ideas, establish new collaborations, meet future partners and expand professional networks—all within a single day.
Not the biggest conference. Perhaps the most connected.
Whether you are looking for scientific inspiration, strategic partnerships, investment opportunities or simply want to experience one of Europe’s most dynamic life science regions firsthand, life – the biomedical convention 2027 is the place to be. Join us in Heidelberg and become part of the conversations shaping the future of biomedicine.